ABOUT MEDICEM INSTITUTE
MEDICEM Institute, the R&D centre of MEDICEM Group, focuses on developing proprietary bioanalogic hydrogel technologies and porcine xenografts and applying them to ophthalmic surgery, tissue regeneration and gynaecology.
MEDICEM Institute’s laboratories are equipped with state-of-the-art instrumentation for conducting research into polymer science, visual and physiological optics, and biomaterial biocompatibility.
Continuing an investigative tradition dating back to Otto Wichterle, our current scientific team includes researchers with backgrounds in biophysics, chemistry, biochemistry and electrical engineering and experience from both academic and industrial institutions.
VLADIMÍR A. STOY – Chief Science Officer
MARTINA PLISOVÁ – R&D Director
RENATA NOVÁKOVÁ – Chief Finance Officer